TScan Therapeutics (TCRX) Cash & Equivalents (2020 - 2026)
TScan Therapeutics (TCRX) recorded Cash & Equivalents of $73.04 million in Q3 2026, down 56.9% from $169.51 million a year earlier and down 27.1% from the prior quarter.
TScan Therapeutics (TCRX) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, TScan Therapeutics reported Cash & Equivalents of $152.41 million, down 14.7% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of 34.4% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $178.69 million in FY2024 (+34.0%), $133.36 million in FY2023 (+11.1%), $120.03 million in FY2022 (-25.6%) and $161.41 million in FY2021 (+363.9%).
- The Q3 2026 figure is the lowest quarterly Cash & Equivalents since Q4 2020.
- On a year-over-year basis, Cash & Equivalents has declined for four consecutive quarters, with an average decline of 11.1% over the last eight quarters.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 363.9% in Q4 2021, against a decline of 56.9% in Q3 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $100.2 million (Q2 2026), $128.06 million (Q1 2026) and $152.41 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | 16,287.00 |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | 4.89 Bn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 16.91 Bn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | 10.77 Bn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 9.55 Bn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | 400.00 Mn |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | 3.88 Bn |
| 10 | TScan Therapeutics | 18.87 Mn | -434.83 Mn | - | 73.04 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 73.04 Mn |
| Jun 30, 2026 | 100.20 Mn |
| Mar 31, 2026 | 128.06 Mn |
| Dec 31, 2025 | 152.41 Mn |
| Sep 30, 2025 | 169.51 Mn |
| Jun 30, 2025 | 169.39 Mn |
| Mar 31, 2025 | 154.11 Mn |
| Dec 31, 2024 | 178.69 Mn |
| Sep 30, 2024 | 133.12 Mn |
| Jun 30, 2024 | 242.16 Mn |
| Mar 31, 2024 | 140.51 Mn |
| Dec 31, 2023 | 133.36 Mn |
| Sep 30, 2023 | 155.19 Mn |
| Jun 30, 2023 | 208.84 Mn |
| Mar 31, 2023 | 95.61 Mn |
| Dec 31, 2022 | 120.03 Mn |
| Sep 30, 2022 | 137.31 Mn |
| Jun 30, 2022 | 125.60 Mn |
| Mar 31, 2022 | 140.84 Mn |
| Dec 31, 2021 | 161.41 Mn |
TScan Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TCRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "TCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();